BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, has announced an exclusive partnership with KRISHGEN BioSystems. KRISHGEN, a prominent provider of life science research tools and services with over two decades of experience in India, Bangladesh, and Nepal, will work with BioIVT to offer high-quality, reliable research solutions. This collaboration combines KRISHGEN’s strong regional presence and expertise with BioIVT’s industry-leading products, creating new opportunities for researchers across South Asia to access cutting-edge resources for clinical research.
BioIVT has entered into an exclusive agreement with KRISHGEN BioSystems, a leading provider of life science research tools in India, Bangladesh, and Nepal. Under the terms of the partnership, KRISHGEN will exclusively represent BioIVT’s extensive portfolio of biofluids, tissues, cell products, media, and subcellular fractions/enzymes across these key South Asian markets. These biological materials are crucial for advancing research in drug discovery, development, toxicology, and personalized medicine.
The collaboration aims to streamline access to high-quality research materials, offering faster lead times, competitive pricing, and ongoing technical support. This partnership will provide researchers in the region with an enhanced research experience and the necessary resources to accelerate their scientific efforts.
“We are thrilled to collaborate with KRISHGEN BioSystems, and we believe this agreement will significantly advance life sciences research in India and beyond,” said Dimas Neto, Director of Global Channel Partnerships at BioIVT. “Together, we are committed to supporting scientific innovations that have the potential to transform healthcare and improve patient outcomes worldwide.”
Krisha Jain, VP of International Business Development at KRISHGEN BioSystems, expressed similar enthusiasm: “This exclusive distribution agreement with BioIVT is a significant step in strengthening our partnership. Both KRISHGEN and BioIVT share a commitment to providing researchers with the highest quality biological materials, and we believe this collaboration will continue to drive our mutual success.”
About BioIVT
BioIVT accelerates medical breakthroughs by providing high-quality, personalized biospecimen solutions and research services to the life science and diagnostic industries. The company specializes in control and disease-state samples, including human and animal tissues, ADME-Tox products, blood, biofluids, and cell and gene therapy products. BioIVT’s vast portfolio of clinical specimens supports precision medicine research and the advancement of patient care by pairing clinical data with biological samples. With its technical expertise, exceptional customer service, and unparalleled access to biospecimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
About KRISHGEN BioSystems
KRISHGEN BioSystems is a privately owned biotech company specializing in providing high-quality tools and reagents for life science research. With a strong background in immunology, KRISHGEN is committed to delivering unique assays, reagents, and consumables to researchers. The company is certified and accredited, with a focus on developing innovative solutions that support scientific discovery and advancements in life sciences.
